LinkinVax
LinkinVax is a protein-based vaccines founded in 2020.
2
Funding Rounds
$12.2m
Money raised
Overview
LinkinVax is a protein-based vaccines founded in 2020.
- Website:
- Headquarters: Paris
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company LinkinVax has raised a total of $12.15m in funding over 2 rounds.
Key Insights:
- LinKinVax January 2023 Series A Funding Round: $7.8m
- LinkinVax Seed round, February 2022: $4.35m
LinKinVax January 2023 Series A Funding Round
$7.8m
LinkinVax Seed round, February 2022
$4.35m